首页 | 本学科首页   官方微博 | 高级检索  
检索        

癌症患者医院感染危险因素配对病例对照研究
引用本文:杨福利,陈瑛.癌症患者医院感染危险因素配对病例对照研究[J].天津医科大学学报,1999,5(3):23-24,51.
作者姓名:杨福利  陈瑛
作者单位:[1]天津医科大学附属卫校 [2]天津市肿瘤医院检验科
摘    要:目的 探讨癌症患者医院感染的危险因素,对制定防止医院感染发生的措施提供依据。方法 采用流行病学配对研究方法对168例医院感染癌症病作168名对照病例进行了配对调查。结果:(1)抗肿瘤经或免疫抑制剂的应用与癌症病人医院感染发病有非常密切的关系(X^2=107.02,P〈0.01,OR=13.6,95%CI7.16~21.78)。(2)各种介入性检诊或治疗手段的应用也是造成癌症病人医院感染的主要危险因

关 键 词:癌症  医院感染  危险因素  配对研究

A MATCHED CASE-CONTROL STUDY ON RISK FACTORS OF NOSOCOMI AL INFECTION AMONG PATIENTS WITH CANCER
Yang Fu Li,Chen ying,Wang Xiang.A MATCHED CASE-CONTROL STUDY ON RISK FACTORS OF NOSOCOMI AL INFECTION AMONG PATIENTS WITH CANCER[J].Journal of Tianjin Medical University,1999,5(3):23-24,51.
Authors:Yang Fu Li  Chen ying  Wang Xiang
Institution:The Health School of Tianjin Medical University 300203
Abstract:Objective :To investigate the risk factors of nosocomial infection among patients with cancer,and to provide the basis for nosocomial infection control and prevention.Methods:168 paris of cancer patients were selected for 1:1 case control study.Results:The results showed that the risk factors of nosocomial infection among cancer patients are: A) Using anticancer medicine or immunity inhibitors , it is the most important risk factor ( OR =13.6,95%, CI :7.16~21.78, P < 0. 01) . B)Various intervenient diagnostic examinations and treatment are the major risk factors. C)Misusing antibioctics is also a risk factor for it. D)An other result showed that operating time has a significantly scale correlation with it (chisquare is 43.22 , P < 0. 01) . Conclusion: The results show that when giving immunosuppressive drug to patients with cancer,we should control dose of the drug and duration of giving the drug and avoid misuse of autibiotic.When carring out intervenient examinations and therapy, we must disinfect strictly and shorten operating time to prevent cross infection nosocomial.
Keywords:cancer  patient  nosocomial  infection  risk factor  case-control study
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号